Dana Genetic A/S: Financial statements 2019
CVR: 37298182
Source: annual report 2019, Danish Business Authority
01/10/2018 – 30/09/2019
Dana Genetic A/S (CVR 37298182) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -360,567 and a net result of DKK -490,214 compared with DKK -875,927 the year before. Equity in the 2019 report amounted to DKK -2,141,594.
- Gross Profit
- DKK -360,567
- Profit/Loss
- DKK -490,214
- Equity
- DKK -2,141,594
- Total Assets
- DKK 176,096
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -361K | -490K | -2.1M | - |
| 2018 | - | -639K | -876K | -1.7M | - |
| 2017 | - | -342K | -866K | -775K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of May 1, 2019, REVISION SJÆLLAND GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of Dana Genetic A/S.
As of May 1, 2019, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of Dana Genetic A/S.
Dana Genetic A/S has published its annual report for 2018. Gross profit came to DKK -639,266, and the net result was DKK -875,927.
About Dana Genetic A/S
Dana Genetic A/S was a Danish company of the type Aktieselskab based in Gentofte, founded in 2015. The company has been dissolved on 14 February 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2021, the company reported a gross profit of DKK -46,878 and a net result of DKK 37,646 compared with DKK -474,616 the year before. Equity in the 2021 report amounted to DKK -2,578,564.